Diabetes Claim Warnings Signal Spread Of Violative Products
This article was originally published in The Tan Sheet
Executive Summary
CDER says a product marketed as a supplement contains three pharmaceutical ingredients, including phenformin, banned in 1978 because of the occurrence of lactic acidosis in patients. Trade group executives say warnings to 14 firms making diabetes and other disease claims demonstrate that noncompliant businesses will target more health conditions of growing concern to consumers.
You may also be interested in...
Mannatech Makes Hash Of Ingredient Identities In Label, Online Claims
Mannatech crosses FDA line on promoting supplements to treat inflammation and tripped on labeling regulations in differentiating MannaBears and other products, according to a warning letter. A second warning published Nov. 21 noted to contract manufacturer Vita-Pure's ingredient testing problems.
Supplement's Noncompliant Diabetes Claims Also Fail NAD Review
"We actually stopped advertising that [claim] many months ago after receiving your letter," HFL Solutions tells NAD.
Spiked “Supplements” For Diabetes, Pain On The Rise
FDA is seeing supplements spiked with Rx ingredients indicated for pain management and diabetes treatment, and needs industry help identifying violators, CFSAN head Michael Landa says.